⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDGL News
Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
MDGL
Form 8-K
sec.gov
MDGL
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Ribo und Ribocure geben exklusive globale Lizenzvereinbarung mit Madrigal für neuartige siRNA-Therapeutika gegen MASH bekannt USA - Deutsch USA - English APAC - Traditional Chinese USA - English APAC - English USA - español USA - Français
prnewswire.com
MDGL
Ribo et Ribocure annoncent un accord de licence mondial exclusif avec Madrigal pour de nouvelles thérapies pARNi ciblant la stéatohépatite associée à un dysfonctionnement métabolique (MASH) USA - Français USA - English APAC - English USA - English APAC -
prnewswire.com
MDGL
Ribo y Ribocure anuncian un acuerdo de licencia global exclusivo con Madrigal USA - español USA - English APAC - English USA - English APAC - Traditional Chinese
prnewswire.com
MDGL
Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH USA - English USA - English APAC - English
prnewswire.com
MDGL